Market Overview - In September, A-shares experienced significant volatility, with the Shanghai Composite Index attempting to breach 3900 points but failing, even dipping below 3800 points at times [1] - The performance varied across sectors, with technology growth sectors like semiconductors and AI showing strong activity, while traditional sectors like banking and non-bank financials lagged [1] - The Federal Reserve announced a 0.25 percentage point interest rate cut, the first of the year, which may attract foreign capital into the Hong Kong and A-share markets, enhancing market liquidity [1][2] Stock Recommendations - A total of 26 brokerages have released stock recommendations for October, covering 196 stocks, with a notable focus on the information technology sector [2][4] - Stocks like Zhaoyi Innovation, Luxshare Precision, and WuXi AppTec appeared most frequently in recommendations, with Zhaoyi Innovation being highlighted for its strong market position and recent performance [4][6] - The technology sector's stocks generally performed well in September, with several stocks increasing over 20%, while financial and consumer sectors underperformed [5][7] Economic Indicators - The People's Bank of China announced a release of 1.1 trillion yuan through open market operations and reverse repos, which is expected to boost market liquidity and support A-share performance post-holiday [2][6] - The anticipated "14th Five-Year Plan" and changes in capital market policies are expected to create investment opportunities [2][7] Sector Focus - Analysts suggest focusing on technology growth sectors, particularly those related to AI, smart manufacturing, and digital economy, as they are likely to benefit from recent market dynamics [2][8] - The performance of the Hang Seng Technology Index, which rose significantly, indicates a positive outlook for tech-related stocks in the A-share market [1][2] Future Outlook - Following the National Day holiday, A-shares are expected to continue a gradual upward trend, supported by strong performances in both US and Hong Kong markets during the holiday [1][2] - Analysts recommend monitoring the potential impact of further Federal Reserve rate cuts on market sentiment and foreign capital inflows [8][9]

Group 1 - UBS Group's short position in WuXi AppTec's H-shares increased from 1.95% to 3.55% as of September 29 [1]

Group 1 - The US stock market showed mixed performance, with the Dow Jones rising by 0.5%, while the Nasdaq initially increased before falling by 0.3%, and the S&P 500 remained stable [3] - The Golden Dragon Index, which reflects the performance of Chinese concept stocks, declined by 1.2% [3] Group 2 - The Hong Kong stock market performed well last week, with the Hang Seng Index gaining 1,012 points or 3.88%, closing at 27,140 points, while the Tech Index rose by 6.9% to close at 6,622 points [4] - Semiconductor company SMIC (00981.HK) was the best-performing constituent stock, rising nearly 25% over the week, with six other stocks also increasing by over 10%, including Kuaishou (01024.HK) up over 17% and Xinyi Solar (00968.HK) up 14.7% [4] - The worst-performing constituent stock was Pop Mart (09992.HK), which fell by over 4%, with its stock price down more than 25% from its peak [4] - Real estate-related stocks experienced adjustments, with China Resources Mixc (01209.HK) down 3.5%, Longfor (00960.HK) and R&F Properties (01109.HK) down nearly 2.4% and 1.8% respectively, while China Overseas (00688.HK) slightly outperformed peers with a 0.5% increase [4] - Zijin Mining's spin-off, Zijin Gold International (02259.HK), had a strong debut, being quickly included in the Hang Seng Composite Index, with its stock price closing at 120.6 HKD, nearly 90% higher than its IPO price [4] Group 3 - The Hang Seng Index remained above the 10-day moving average (26,600 points), indicating a stable trend, and as long as it stays above this level, the upward trend is expected to continue [5]

Core Viewpoint - The October market is expected to continue a structural trend of "growth-oriented with cyclical support," driven by long-term policy support, intensive industrial catalysts, and a loose liquidity environment [1][6]. Group 1: Stock Recommendations - A total of 111 stocks have been included in the "golden stock" portfolios of 13 brokerage firms for October, with notable mentions including SMIC, WuXi AppTec, Huayou Cobalt, Hikvision, and Haier Smart Home [1][3]. - The most recommended stocks, each receiving two endorsements from different brokerages, include Zhaoyi Innovation, WuXi AppTec, Luoyang Molybdenum, Ecovacs, and SMIC, among others [4][3]. - The technology sector, particularly stocks like Zhaoyi Innovation, Datong Technology, and SMIC, is favored by brokerages, indicating a strong preference for TMT (Technology, Media, and Telecommunications) stocks [4][5]. Group 2: Market Outlook - Historical data shows that the A-share market typically experiences a rebound after the National Day holiday, with over 70% probability of an increase in the first week post-holiday [7]. - Multiple significant events are expected to occur in October, including the Federal Reserve's meeting and the release of Q3 reports, which could inject new vitality into the market [7][8]. - The technology growth sector is anticipated to present more opportunities in October, with expectations of a Federal Reserve rate cut boosting market sentiment [8].

Core Viewpoint - The article highlights the investment opportunities in the A-share market for October, emphasizing a structural trend where growth sectors, particularly technology and high-end manufacturing, are expected to lead the market due to supportive policies, industry catalysts, and a loose liquidity environment [1][6]. Group 1: Recommended Stocks - A total of 111 stocks have been recognized by 13 brokerage firms in their October "golden stock" lists, with notable mentions including SMIC, WuXi AppTec, Huayou Cobalt, Hikvision, and Haier Smart Home [1][3]. - The stocks with the highest recommendation frequency include SMIC, WuXi AppTec, Huayou Cobalt, Hikvision, and Haier Smart Home, each receiving recommendations from two brokerage firms [3][4]. Group 2: Industry Insights - The technology sector, particularly TMT (Technology, Media, and Telecommunications), is expected to be a key focus area, driven by liquidity and market trends, with significant catalysts such as ongoing industry advancements and the anticipated interest rate cuts by the Federal Reserve [4][8]. - SMIC is positioned as a leading player in the advanced wafer foundry market, benefiting from the surge in AI chip demand and domestic substitution trends, with revenue from advanced processes projected to grow by 68% year-on-year by 2025 [5]. - WuXi AppTec is expected to see growth in orders due to an uptick in global biotech investment and demand for innovative drug CDMO services, driven by recent positive performance from major CXO companies [5]. Group 3: Market Outlook - Historical data suggests that the A-share market typically experiences a rebound after the National Day holiday, with over 70% probability of an increase in the first week post-holiday, supported by various upcoming significant events [7]. - The market is anticipated to gain momentum from the convergence of favorable policies, confirmed earnings bottoms, and adequate liquidity, leading to a potential new upward trend [7][8]. - The focus for October is expected to be on technology growth sectors, with the Hong Kong market also benefiting from unique structural factors and external liquidity expectations [8].

Core Viewpoint - WuXi AppTec (603259)(02359) announced the conversion and issuance of 14.1858 million H-shares based on a $500 million zero-coupon secured convertible bond maturing in 2025, effective September 30, 2025 [1] Group 1 - The company will issue H-shares as part of the conversion of the convertible bond [1] - The convertible bond is valued at $500 million and is set to mature in 2025 [1] - The total number of H-shares to be issued is 14.1858 million [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 確認 公司名稱： 無錫藥明康德新藥開發股份有限公司 呈交日期： 2025年9月30日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02359 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 無錫藥明康德新藥開發股份有限公司 呈交日期： 2025年9月30日 (viii) 有關債券、借貸股份、票據或公司債券的信託契約/平邊契據經已製備及簽署，有關詳情已送呈公司註冊處處長存檔（如法律如此規定）。 第一章節註釋： 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02359 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | ...

Market Overview - The Hong Kong stock market experienced a rebound, with the Hang Seng Index rising by 0.87% to close at 26,855.56 points, and a total trading volume of HKD 314.93 billion [1] - The Hang Seng Index increased by 7.09% for the month, while the Hang Seng China Enterprises Index and the Hang Seng Tech Index rose by 6.79% and 13.95%, respectively [1] Investment Insights - According to China Merchants Securities International, the short-term volatility in the Hong Kong market is expected, but the long-term upward trend remains intact, with a focus on AI technology and non-ferrous metals as key investment themes [1] - Everbright Securities noted that despite the continuous rise in the Hong Kong market over recent months, overall valuations remain low, indicating a high cost-performance ratio for long-term investments [1] Blue-Chip Performance - Kuaishou Technology (01024) reached a three-year high, closing up 7.22% at HKD 84.6, contributing 26.93 points to the Hang Seng Index [2] - WuXi AppTec (02359) rose by 8.11% to HKD 118.7, contributing 6.26 points, while Sunny Optical Technology (02382) increased by 5.6% to HKD 90.45, contributing 5.37 points [2] Sector Performance - Technology stocks saw a collective rise, with Kuaishou up over 7%, Bilibili up over 6%, and Alibaba and NetEase both up over 2% [3] - Semiconductor stocks performed strongly, with Hua Hong Semiconductor rising nearly 11% to HKD 80 [3] - The pharmaceutical sector continued its upward trend, with WuXi AppTec up over 8% [3] AI and Technology Developments - DeepSeek announced the release of its new language model, DeepSeek-V3.2-Exp, which significantly reduces service costs by over 50% for developers [4][5] - The AI application sector is gaining traction, with companies like Huya Technology (01860) rising by 10.25% [4] Pharmaceutical Sector Insights - The pharmaceutical sector remains strong, with WuXi AppTec and other companies like HAPO (02142) and Zai Lab (09688) showing significant gains [5] - The impact of potential tariffs on patented drugs by the U.S. is considered limited for China's innovative drug industry [6] Non-Ferrous Metals Sector - The non-ferrous metals sector is active, with Jiangxi Copper (00358) rising by 8.85% to HKD 30.5, and Ganfeng Lithium (01772) up by 8.66% to HKD 43.14 [5] - The Ministry of Industry and Information Technology's plan for the non-ferrous metals industry aims for an average annual growth of around 5% from 2025 to 2026 [7] Airline Sector Performance - Major airlines saw collective gains, with China Eastern Airlines (00670) up 6.73% to HKD 3.33 [7] - The domestic flight ticket bookings for the upcoming National Day and Mid-Autumn Festival have surpassed 10.19 million, indicating strong demand [8] Notable Stock Movements - MicroPort Medical (00853) rose by 5.27% following the announcement of a restructuring in its cardiac management business [9] - Sanhua Intelligent Controls (02050) increased by 6.62% as Tesla plans to expand its humanoid robot production [10] - UBTECH Robotics (09880) saw an 8.98% rise, attributed to significant new orders and a positive outlook from Morgan Stanley [11] New IPO Highlights - Xipuni (02583) surged by 258.11% on its debut, closing at HKD 106, focusing on gold watch design and manufacturing [12] - Zijin Gold International (02259) rose by 68.46% to HKD 120.6, marking the second-largest IPO in Hong Kong this year [14]

Core Insights - The medical services sector experienced a rise of 2.89% on September 30, with WuXi AppTec leading the gains [1] - The Shanghai Composite Index closed at 3882.78, up 0.52%, while the Shenzhen Component Index closed at 13526.51, up 0.35% [1] Medical Services Sector Performance - WuXi AppTec (603259) closed at 112.03, with a gain of 6.42% and a trading volume of 707,400 shares, amounting to a transaction value of 7.792 billion [1] - Other notable performers included Haoyuan Pharmaceutical (688131) with a 6.36% increase, Boteng Co., Ltd. (300363) up by 5.31%, and MediSino (688202) rising by 4.85% [1] - The sector saw a net inflow of 1.095 billion in main funds, while retail investors experienced a net outflow of 549 million [2][3] Fund Flow Analysis - WuXi AppTec had a net inflow of 926 million from main funds, but a net outflow of 659 million from speculative funds [3] - Other companies like Kanglong Chemical (300759) and Kailai Ying (002821) also showed significant fund flow dynamics, with varying levels of net inflow and outflow [3] - The overall trend indicates a mixed sentiment among retail and institutional investors within the medical services sector [2][3]